Advertisement

Topics

Sequella Incorporated Company Profile

02:26 EST 19th December 2018 | BioPortfolio

Sequella, Inc. is poised to become a biotechnology leader in the fight against global infectious diseases. Founded in 1997 by Drs. Nacy and Einck, Sequella is developing novel therapeutics, diagnostics, and technologies to address underserved and highly prevalent diseases starting with Tuberculosis (TB). Sequella's strategy for growth and success focuses on leveraging the proven experience of its executive management and scientific talent, advancing novel research and discovery compounds with best-in-class potential, and delivering new products commercialized through strategic collaboration and alliances.

Location

9610 Medical Center Drive Suite 200
Rockville
Maryland
20850
United States of America

Contact

Phone: 301-762-7776
Fax: 301-762-7778
Email: mail@sequella.com


News Articles [7 Associated News Articles listed on BioPortfolio]

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPO...

Sequella Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

Sequella Inc Medical Equipment Deals and Alliances Profile [Report Updated: 12062018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

Sequella Inc Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [41 Associated Companies listed on BioPortfolio]

Sequella Incorporated

Sequella, Inc. is poised to become a biotechnology leader in the fight against global infectious diseases. Founded in 1997 by Drs. Nacy and Einck, Sequella is developing novel therapeutics, diagnosti...

Sequella, Inc.

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for infectious diseases. The company leverages its global influence, R&D platforms and infectious ...

Sequella Inc.

Sequella is a clinical stage pharmaceutical company focused on identifying, developing, and commercializing novel antibiotics to treat infectious diseases, particularly those for ...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Sequella Incorporated" on BioPortfolio

We have published hundreds of Sequella Incorporated news stories on BioPortfolio along with dozens of Sequella Incorporated Clinical Trials and PubMed Articles about Sequella Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequella Incorporated Companies in our database. You can also find out about relevant Sequella Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record